Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

NHE-3 inhibitors in early development at Merck KGaA

July 18, 2003

United Therapeutics files IND for i.v. Remodulin

July 15, 2003

Improved survival with carvedilol compared to metoprolol in chronic heart failure

July 15, 2003

Novel Wyeth compounds that increase HDL cholesterol

July 11, 2003

Vasogen initiates patient enrollment in pivotal ACCLAIM trial

July 10, 2003

Stent-induced restenosis reduced by inhibitor of PDGFR-TK

July 10, 2003

FDA advisory committee schedules Ranexa NDA for review

July 9, 2003

Pravastatin improves cardiovascular risk in women with coronary heart disease

July 8, 2003

Safer antiarrhythmic agents newly developed at ARYx

July 8, 2003

Actelion presents new urotensin-II antagonists for hypertension, atherosclerosis, angina, etc.

July 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...